ArticleTechnology in cancer research & treatment
Whole-Field Continuous Wave Diffuse Reflectance Imaging for Breast Lesion Characterization: Clinical Results.
Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectiveThis work introduces MamoRef, an innovative whole-field, near infrared spectroscopy based device for adjunctive breast examination, aiming to help classify benign and malignant lesions in women. Utilizing low-power, non-ionizing red and near-infrared lasers, it provides metabolic information to aid physicians in characterizing lesions in BI-RADS II to IV patients, offering a non-invasive screening alternative.ApproachClinical studies were conducted, benchmarking MamoRef against conventional imaging and core biopsies. The device generates 2D maps of relative oxyhemoglobin, deoxyhemoglobin, and oxygen saturation. NIRS-specialized professionals, with basic clinical training, independently scored MamoRef images using a 6-point scale analog to BI-RADS. Scores were averaged and normalized for biopsy comparison.Main resultsThe studied clinical cases show promising outcomes. For neoproliferative lesions, MamoRef images reveals high deoxygenated hemoglobin and diffuse high oxygenated/total hemoglobin, suggesting neovascularization around necrotic tissue. Preliminary receiver operating characteristic analysis yielded an area under the curve of 0.77. At a 0.6 threshold, MamoRef showed 70% accuracy and 74% specificity.SignificancePreliminary results suggest MamoRef can potentially differentiate benign from malignant lesions detected by standard imaging. Trained clinicians might detect and characterize lesions using these metabolic maps. Further larger-scale studies are needed to validate these findings and improve the technology, positioning MamoRef as a potential low-cost, accessible adjunctive screening tool.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.